• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    LHC Group filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8/3/22 4:35:52 PM ET
    $LHCG
    Medical/Nursing Services
    Health Care
    Get the next $LHCG alert in real time by email
    lhcg-8k_20220803.DOCX.htm
    false 0001303313 0001303313 2022-08-03 2022-08-03

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): August 3, 2022

     

    LHC GROUP, INC.

    (Exact name of registrant as specified in charter)

     

     

    Delaware

     

    001-33989

     

    71-0918189

    (State or Other Jurisdiction
    of Incorporation)

     

    (Commission
    File Number)

     

    (I.R.S. Employer
    Identification No.)

     

    901 Hugh Wallis Road South, Lafayette, LA 70508

    (Address of Principal Executive Offices) (Zip Code)

    (337) 233-1307
    (Registrant’s telephone number, including area code)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act.

    Title of each class

    Trading Symbol(s)

    Name of each exchange on which registered

    Common Stock, par value $0.01 per share

    LHCG

    NASDAQ Global Select Market

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company  ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act  ☐

     


     

    Item 2.02 Results of Operations and Financial Condition.

    On August 3, 2022, the Company issued a press release announcing its financial results for the second quarter ended June 30, 2022.  A copy of the press release is furnished with this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.

    The information furnished pursuant to Item 2.02 and Exhibit 99.1 of this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report, regardless of any general incorporation language in the filing, except as shall be expressly set forth by specific reference in such filing.

    Item 7.01 Regulation FD Disclosure

    Item 2.02 of this Current Report on Form 8-K is incorporated herein by reference.

    In addition, a copy of the supplemental slides is attached to this report as Exhibit 99.2 and incorporated herein by reference.

    The information furnished pursuant to Item 7.01 and Exhibit 99.2 of this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report, regardless of any general incorporation language in the filing, except as shall be expressly set forth by specific reference in such filing.

    Item 9.01 Financial Statements and Exhibits

    (d)       Exhibits

    The following exhibits are furnished with this Current Report on Form 8-K:

    EXHIBIT NO.

     

    DESCRIPTION

     

     

     

    99.1

     

    Press Release, dated August 3, 2022, announcing the Company’s financial results for the second quarter ended June 30, 2022 (furnished only).

    99.2

     

    Second Quarter 2022 Supplemental Financial Information (furnished only).

    104

     

    Cover Page Interactive Data File (embedded within the Inline XBRL document)

     


     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

     

    LHC GROUP, INC.

     

     

     

    Date: August 3, 2022

    By:

    /s/ Dale Mackel

     

     

    Name:

    Dale Mackel

     

     

    Title:

    Chief Financial Officer

     

     

     

    Get the next $LHCG alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LHCG

    DatePrice TargetRatingAnalyst
    4/4/2022$172.00 → $170.00Outperform → Sector Perform
    RBC Capital Mkts
    3/10/2022$175.00 → $185.00Buy
    Truist Securities
    2/28/2022$184.00 → $181.00Outperform
    Credit Suisse
    2/24/2022$190.00 → $170.00Buy
    Benchmark
    11/10/2021$149.00 → $151.00Market Perform
    SVB Leerink
    11/5/2021$207.00 → $171.00Equal-Weight
    Barclays
    11/5/2021$192.00 → $180.00Outperform
    RBC Capital
    11/5/2021$191.00 → $184.00Outperform
    Credit Suisse
    More analyst ratings

    $LHCG
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • UFP Industries Set to Join S&P MidCap 400; Otter Tail to Join S&P SmallCap 600

      NEW YORK, Feb. 16, 2023 /PRNewswire/ -- S&P SmallCap 600 constituent UFP Industries Inc. (NASD: UFPI) will replace LHC Group Inc. (NASD: LHCG) in the S&P MidCap 400, and Otter Tail Corp. (NASD: OTTR) will replace UFP Industries in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, February 23. S&P 500 constituent UnitedHealth Group Inc. (NYSE:UNH) is acquiring LHC Group in a deal expected to be completed soon pending final conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effectiv

      2/16/23 6:04:00 PM ET
      $LHCG
      $OTTR
      $SPGI
      $UFPI
      Medical/Nursing Services
      Health Care
      Electric Utilities: Central
      Utilities
    • LHC Group announces third quarter 2022 financial results

      LAFAYETTE, La., Nov. 2, 2022 /PRNewswire/ -- LHC Group, Inc. (NASDAQ:LHCG) announced its financial results for the quarter ended September 30, 2022. Third Quarter 2022 Financial Results Net service revenue increased 2.0% to $576.9 million.Net income attributable to LHC Group's common stockholders was $17.3 million, or $0.56 per diluted share.Adjusted net income attributable to LHC Group's common stockholders was $32.6 million, or $1.06 adjusted earnings per diluted share.Adjusted EBITDA was $60.3 million.A reconciliation of all non-GAAP financial results in this release appea

      11/2/22 4:15:00 PM ET
      $LHCG
      Medical/Nursing Services
      Health Care
    • LHC Group to report third quarter 2022 earnings results on November 2, 2022

      LAFAYETTE, La., Oct. 19, 2022 /PRNewswire/ -- LHC Group, Inc. (NASDAQ:LHCG) today announced details for the release of its results for the third quarter ended September 30, 2022. LHC Group plans to issue its earnings results after the market closes on Wednesday, November 2, 2022. In light of the Company's previously announced agreement to combine with Optum, LHC Group will not conduct a quarterly earnings call to discuss the third quarter results. About LHC Group, Inc.LHC Group, Inc. is a national provider of in-home healthcare services and innovations for communities around t

      10/19/22 7:00:00 AM ET
      $LHCG
      Medical/Nursing Services
      Health Care

    $LHCG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Reed W Earl Iii returned $23,595,490 worth of shares to the company (138,797 units at $170.00), closing all direct ownership in the company

      4 - LHC Group, Inc (0001303313) (Issuer)

      2/22/23 4:39:24 PM ET
      $LHCG
      Medical/Nursing Services
      Health Care
    • SEC Form 4: Nixon Ronald T returned $4,607,000 worth of shares to the company (27,100 units at $170.00), closing all direct ownership in the company

      4 - LHC Group, Inc (0001303313) (Issuer)

      2/22/23 4:38:04 PM ET
      $LHCG
      Medical/Nursing Services
      Health Care
    • SEC Form 4: Azare Monica F returned $5,185,000 worth of shares to the company (30,500 units at $170.00), closing all direct ownership in the company

      4 - LHC Group, Inc (0001303313) (Issuer)

      2/22/23 4:38:30 PM ET
      $LHCG
      Medical/Nursing Services
      Health Care

    $LHCG
    Leadership Updates

    Live Leadership Updates

    See more
    • Agape Care Group Appoints Carry vandenMaagdenberg as Its Chief Technology and Innovation Officer and Matt Winer to Chief Operations Officer Post

      Agape Care Group, a leading hospice and palliative care provider, announced today that it is has appointed Carry vandenMaagdenberg as its Chief Technology and Innovation Officer and welcomes Matt Winer to the company as its Chief Operations Officer. Both leaders are health care industry veterans who will lead Agape Care Group forward as it continues to serve a growing number of patients across the Southeast region. Winer joins Agape Care Group from LHC Group (NASDAQ:LHCG) where he led the company's Home Health Division in the Northeast. He has health care experience in South Carolina, having served in operational leadership roles for MUSC Health based in Charleston. He has also led teams i

      4/16/21 2:47:00 PM ET
      $LHCG
      $AMED
      Medical/Nursing Services
      Health Care
    • LHC Group announces corporate governance changes for its 2021 annual meeting

      LAFAYETTE, La., Feb. 17, 2021 /PRNewswire/ -- LHC Group, Inc. (NASDAQ: LHCG) announced a number of corporate governance and board changes that will go into effect with the company's annual shareholder meeting on June 10, 2021. These changes include a mandatory retirement age of 75 for board members as well as the appointment of new chairs of the audit, compensation, corporate development and nominating and corporate governance committees. In addition, LHC Group announced that W.J. "Billy" Tauzin, will retire from the board, effective June 10, 2021.  Following a long and distinguished career representing Louisiana's Third Congressional District in the U.S. House of Representatives, Congressm

      2/17/21 4:01:00 PM ET
      $LHCG
      Medical/Nursing Services
      Health Care

    $LHCG
    Financials

    Live finance-specific insights

    See more
    • LHC Group announces third quarter 2022 financial results

      LAFAYETTE, La., Nov. 2, 2022 /PRNewswire/ -- LHC Group, Inc. (NASDAQ:LHCG) announced its financial results for the quarter ended September 30, 2022. Third Quarter 2022 Financial Results Net service revenue increased 2.0% to $576.9 million.Net income attributable to LHC Group's common stockholders was $17.3 million, or $0.56 per diluted share.Adjusted net income attributable to LHC Group's common stockholders was $32.6 million, or $1.06 adjusted earnings per diluted share.Adjusted EBITDA was $60.3 million.A reconciliation of all non-GAAP financial results in this release appea

      11/2/22 4:15:00 PM ET
      $LHCG
      Medical/Nursing Services
      Health Care
    • LHC Group to report third quarter 2022 earnings results on November 2, 2022

      LAFAYETTE, La., Oct. 19, 2022 /PRNewswire/ -- LHC Group, Inc. (NASDAQ:LHCG) today announced details for the release of its results for the third quarter ended September 30, 2022. LHC Group plans to issue its earnings results after the market closes on Wednesday, November 2, 2022. In light of the Company's previously announced agreement to combine with Optum, LHC Group will not conduct a quarterly earnings call to discuss the third quarter results. About LHC Group, Inc.LHC Group, Inc. is a national provider of in-home healthcare services and innovations for communities around t

      10/19/22 7:00:00 AM ET
      $LHCG
      Medical/Nursing Services
      Health Care
    • LHC Group announces second quarter 2022 financial results

      LAFAYETTE, La., Aug. 3, 2022 /PRNewswire/ -- LHC Group, Inc. (NASDAQ:LHCG) announced its financial results for the quarter ended June 30, 2022. Second Quarter 2022 Financial Results Net service revenue increased 5.5% to $576.2 million.Net income attributable to LHC Group's common stockholders was $10.6 million, or $0.35 per diluted share.Adjusted net income attributable to LHC Group's common stockholders was $29.8 million, or $0.98 adjusted earnings per diluted share.Adjusted EBITDA was $53.0 million.A reconciliation of all non-GAAP financial results in this release appears o

      8/3/22 4:15:00 PM ET
      $LHCG
      Medical/Nursing Services
      Health Care

    $LHCG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by LHC Group (Amendment)

      SC 13G/A - LHC Group, Inc (0001303313) (Subject)

      1/26/23 8:52:15 AM ET
      $LHCG
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by LHC Group (Amendment)

      SC 13G/A - LHC Group, Inc (0001303313) (Subject)

      7/11/22 9:48:31 AM ET
      $LHCG
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by LHC Group (Amendment)

      SC 13G/A - LHC Group, Inc (0001303313) (Subject)

      2/10/22 8:22:29 AM ET
      $LHCG
      Medical/Nursing Services
      Health Care

    $LHCG
    SEC Filings

    See more
    • SEC Form S-8 POS filed by LHC Group

      S-8 POS - LHC Group, Inc (0001303313) (Filer)

      2/22/23 4:03:26 PM ET
      $LHCG
      Medical/Nursing Services
      Health Care
    • LHC Group filed SEC Form 8-K: Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Control of Registrant, Leadership Update, Financial Statements and Exhibits

      8-K - LHC Group, Inc (0001303313) (Filer)

      2/22/23 8:30:56 AM ET
      $LHCG
      Medical/Nursing Services
      Health Care
    • SEC Form 10-K filed by LHC Group

      10-K - LHC Group, Inc (0001303313) (Filer)

      2/22/23 6:03:38 AM ET
      $LHCG
      Medical/Nursing Services
      Health Care

    $LHCG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • LHC Group downgraded by RBC Capital Mkts with a new price target

      RBC Capital Mkts downgraded LHC Group from Outperform to Sector Perform and set a new price target of $170.00 from $172.00 previously

      4/4/22 7:19:32 AM ET
      $LHCG
      Medical/Nursing Services
      Health Care
    • Truist Securities reiterated coverage on LHC Group with a new price target

      Truist Securities reiterated coverage of LHC Group with a rating of Buy and set a new price target of $185.00 from $175.00 previously

      3/10/22 10:10:03 AM ET
      $LHCG
      Medical/Nursing Services
      Health Care
    • Credit Suisse reiterated coverage on LHC Group with a new price target

      Credit Suisse reiterated coverage of LHC Group with a rating of Outperform and set a new price target of $181.00 from $184.00 previously

      2/28/22 10:39:19 AM ET
      $LHCG
      Medical/Nursing Services
      Health Care